648 related articles for article (PubMed ID: 33161283)
1. Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study.
Hardy M; Michaux I; Lessire S; Douxfils J; Dogné JM; Bareille M; Horlait G; Bulpa P; Chapelle C; Laporte S; Testa S; Jacqmin H; Lecompte T; Dive A; Mullier F
Thromb Res; 2021 Jan; 197():20-23. PubMed ID: 33161283
[No Abstract] [Full Text] [Related]
2. COVID-19-related laboratory coagulation findings.
Devreese KMJ
Int J Lab Hematol; 2021 Jul; 43 Suppl 1(Suppl 1):36-42. PubMed ID: 34288440
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays.
White D; MacDonald S; Edwards T; Bridgeman C; Hayman M; Sharp M; Cox-Morton S; Duff E; Mahajan S; Moore C; Kirk M; Williams R; Besser M; Thomas W
Int J Lab Hematol; 2021 Feb; 43(1):123-130. PubMed ID: 32892505
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of D-dimer, Weight, and Renal Function-Adjusted Thromboprophylaxis in Patients with Coronavirus Disease 2019 (COVID-19).
Arachchillage DRJ; Shi C; Saliu D; Kozman P; Mi E; Buti N; Kashef E; Copley SJ; Gomez C; Leonard R; Aziz R; Shlebak AA; Laffan M
Semin Thromb Hemost; 2021 Jun; 47(4):436-441. PubMed ID: 33482676
[No Abstract] [Full Text] [Related]
5. Thromboelastometry as a supplementary tool for evaluation of hemostasis in severe sepsis and septic shock.
Andersen MG; Hvas CL; Tønnesen E; Hvas AM
Acta Anaesthesiol Scand; 2014 May; 58(5):525-33. PubMed ID: 24580049
[TBL] [Abstract][Full Text] [Related]
6. Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II.
Favaloro EJ; Lippi G
Semin Thromb Hemost; 2021 Jun; 47(4):333-337. PubMed ID: 34062596
[No Abstract] [Full Text] [Related]
7. Hemostatic System (Fibrinogen Level, D-Dimer, and FDP) in Severe and Non-Severe Patients With COVID-19: A Systematic Review and Meta-Analysis.
Rostami M; Khoshnegah Z; Mansouritorghabeh H
Clin Appl Thromb Hemost; 2021; 27():10760296211010973. PubMed ID: 34933579
[TBL] [Abstract][Full Text] [Related]
8. Complement activation and coagulopathy - an ominous duo in COVID19.
Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
[TBL] [Abstract][Full Text] [Related]
9. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
Swiatkiewicz A; Jurkowski P; Kotschy M; Ciecierski M; Jawień A
Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
[TBL] [Abstract][Full Text] [Related]
10. Disorders of hemostasis during the surgical management of severe necrotizing pancreatitis.
Radenković D; Bajec D; Karamarkovic A; Stefanovic B; Milic N; Ignjatović S; Gregoric P; Milicevic M
Pancreas; 2004 Aug; 29(2):152-6. PubMed ID: 15257107
[TBL] [Abstract][Full Text] [Related]
11. Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness.
Lippi G; Henry BM; Sanchis-Gomar F
Semin Thromb Hemost; 2021 Jun; 47(4):460-462. PubMed ID: 33378783
[No Abstract] [Full Text] [Related]
12. COVID-19-associated coagulopathy and disseminated intravascular coagulation.
Asakura H; Ogawa H
Int J Hematol; 2021 Jan; 113(1):45-57. PubMed ID: 33161508
[TBL] [Abstract][Full Text] [Related]
13. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
Tschopl M; Tsakiris DA; Marbet GA; Labs KH; Jäger K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3208-14. PubMed ID: 9409313
[TBL] [Abstract][Full Text] [Related]
14. Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology.
Chekkal M; Deba T; Hadjali S; Lamara H; Oulaa H; Zouai K; Hariti G
Transfus Clin Biol; 2020 Nov; 27(4):203-206. PubMed ID: 33022374
[TBL] [Abstract][Full Text] [Related]
15. Increased resistance to fibrinolysis activation in patients with coronavirus disease 2019: a case series.
Duque P; Chasco-Ganuza M; Burgos-Santamaria A; Terradillos E
Blood Coagul Fibrinolysis; 2021 Jun; 32(4):298-301. PubMed ID: 33491994
[TBL] [Abstract][Full Text] [Related]
16. Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19).
Henry BM; Benoit SW; Hoehn J; Lippi G; Favaloro EJ; Benoit JL
Semin Thromb Hemost; 2020 Oct; 46(7):859-862. PubMed ID: 32882718
[No Abstract] [Full Text] [Related]
17. Rotational thromboelastometry (ROTEM) profiling of COVID-19 patients.
Mitrovic M; Sabljic N; Cvetkovic Z; Pantic N; Zivkovic Dakic A; Bukumiric Z; Libek V; Savic N; Milenkovic B; Virijevic M; Vucinic V; Milosevic I; Pravdic Z; Suvajdzic N; Fareed J; Antic D
Platelets; 2021 Jul; 32(5):690-696. PubMed ID: 33561381
[TBL] [Abstract][Full Text] [Related]
18. D-dimer Level and Diabetes in the COVID-19 Infection.
Miri C; Charii H; Bouazzaoui MA; Laouan Brem F; Boulouiz S; Abda N; Kouismi H; Bazid Z; Ismaili N; El Ouafi N
Clin Appl Thromb Hemost; 2021; 27():10760296211045902. PubMed ID: 34590493
[TBL] [Abstract][Full Text] [Related]
19. Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis.
Nougier C; Benoit R; Simon M; Desmurs-Clavel H; Marcotte G; Argaud L; David JS; Bonnet A; Negrier C; Dargaud Y
J Thromb Haemost; 2020 Sep; 18(9):2215-2219. PubMed ID: 32668058
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients.
de la Morena-Barrio ME; Bravo-Pérez C; Miñano A; de la Morena-Barrio B; Fernandez-Perez MP; Bernal E; Gómez-Verdu JM; Herranz MT; Vicente V; Corral J; Lozano ML
Sci Rep; 2021 Apr; 11(1):7792. PubMed ID: 33833254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
